Nath Bio-Genes India Ltd posts Rs. 1.43 crore consolidated PAT in Q4 FY2022-23

Nath Bio-Genes (India) Limited has reported Consolidated financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 44.9875 crores during the period ended March 31, 2023 as compared to Rs. 25.2974 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. 1.4369 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 1.3488 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. 0.76 for the period ended March 31, 2023 as compared to Rs. 0.71 for the period ended December 31, 2022.

Financials	Q4 FY2023	Q3 FY2023	% Change
Total Income	₹44.9875 crs	₹25.2974 crs	77.83%
Net Profit	₹1.4369 crs	₹1.3488 crs	6.53%
EPS	₹0.76	₹0.71	7.04%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.44.9875 crores during the period ended March 31, 2023 as compared to Rs.27.2118 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.1.4369 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.-116.3350 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.0.76 for the period ended March 31, 2023 as compared to Rs.-61.22 for the period ended March 31, 2022.

Financials	Q4 FY2023	Q4 FY2022	% Change
Total Income	₹44.9875 crs	₹27.2118 crs	65.32%
Net Profit	₹1.4369 crs	₹-116.3350 crs	101.24%
EPS	₹0.76	₹-61.22	101.24%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.301.3637 crores during the Financial Year ended March 31, 2023 as compared to Rs.278.3623 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.35.0114 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.-67.3853 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.18.42 for the Financial Year ended March 31, 2023 as compared to Rs.-35.46 for the Financial Year ended March 31, 2022.

Financials	Year Ended FY2023	Year Ended FY2022	% Change
Total Income	₹301.3637 crs	₹278.3623 crs	8.26%
Net Profit	₹35.0114 crs	₹-67.3853 crs	151.96%
EPS	₹18.42	₹-35.46	151.95%

Shares of Nath Bio-Genes (India) Limited was last trading in BSE at Rs. 168.65 as compared to the previous close of Rs. 165.15. The total number of shares traded during the day was 3460 in over 153 trades.

The stock hit an intraday high of Rs. 169.00 and intraday low of 163.00. The net turnover during the day was Rs. 575521.00.

Source : Equity Bulls

Keywords

NathBioGenesIndia Q4FY23 FY2023 ResultUpdate